{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:43:59Z","timestamp":1794617039049,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H020010"],"award-info":[{"award-number":["LQ23H020010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400047"],"award-info":[{"award-number":["32400047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2019C03030"],"award-info":[{"award-number":["2019C03030"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01406-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:19:27Z","timestamp":1775650767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning"],"prefix":"10.1038","volume":"10","author":[{"given":"Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-1879","authenticated-orcid":false,"given":"Hongchang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"1406_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrclinonc.2015.160","volume":"12","author":"A Fenner","year":"2015","unstructured":"Fenner, A. Prostate cancer: AS-contemplation, not intervention. Nat. Rev. Clin. Oncol. 12, 623 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James, N. D. et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 403, 1683\u20131722 (2024).","journal-title":"Lancet"},{"key":"1406_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams, I. S. et al. Modern paradigms for prostate cancer detection and management. Med. J. Aust. 217, 424\u2013433 (2022).","journal-title":"Med. J. Aust."},{"key":"1406_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJMcp2209151","volume":"388","author":"PF Pinsky","year":"2023","unstructured":"Pinsky, P. F. & Parnes, H. Screening for prostate cancer. N. Engl. J. Med. 388, 1405\u20131414 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/CM9.0000000000003689","volume":"138","author":"W Li","year":"2025","unstructured":"Li, W. et al. Artificial intelligence in prostate cancer. Chin. Med. J. 138, 1769\u20131782 (2025).","journal-title":"Chin. Med. J."},{"key":"1406_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41585-022-00678-y","volume":"20","author":"MS Lee","year":"2023","unstructured":"Lee, M. S. et al. Relationships between holmium laser enucleation of the prostate and prostate cancer. Nat. Rev. Urol. 20, 226\u2013240 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"1406_CR7","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/cancers14112734","volume":"14","author":"D Chakravarty","year":"2022","unstructured":"Chakravarty, D. et al. Association between incidental pelvic inflammation and aggressive prostate cancer. Cancers 14, 2734 (2022).","journal-title":"Cancers"},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00432-013-1543-9","volume":"140","author":"Y Kitagawa","year":"2014","unstructured":"Kitagawa, Y. et al. Cumulative probability of prostate cancer detection in biopsy according to free\/total PSA ratio in men with total PSA levels of 2.1-10.0 ng\/ml at population screening. J. Cancer Res Clin. Oncol. 140, 53\u201359 (2014).","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"e230431","DOI":"10.1148\/radiol.230431","volume":"309","author":"M Alabousi","year":"2023","unstructured":"Alabousi, M., Ghai, S. & Haider, M. A. MRI-guided minimally invasive focal therapies for prostate cancer. Radiology 309, e230431 (2023).","journal-title":"Radiology"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2013.05.030","volume":"64","author":"MJ Roobol","year":"2013","unstructured":"Roobol, M. J. et al. Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur. Urol. 64, 530\u2013539 (2013).","journal-title":"Eur. Urol."},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/cncr.31337","volume":"124","author":"JT Kearns","year":"2018","unstructured":"Kearns, J. T. et al. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening. Cancer 124, 2733\u20132739 (2018).","journal-title":"Cancer"},{"key":"1406_CR12","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.21037\/qims-23-1379","volume":"14","author":"J Jeong","year":"2024","unstructured":"Jeong, J. et al. Deep learning image reconstruction of diffusion-weighted imaging in evaluation of prostate cancer focusing on its clinical implications. Quant. Imaging Med Surg. 14, 3432\u20133446 (2024).","journal-title":"Quant. Imaging Med Surg."},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer-2020 Update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79, 243\u2013262 (2021).","journal-title":"Eur. Urol."},{"key":"1406_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03860-3","volume":"21","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. J. Transl. Med. 21, 40 (2023).","journal-title":"J. Transl. Med."},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.med.60.042307.110714","volume":"60","author":"DV Makarov","year":"2009","unstructured":"Makarov, D. V., Loeb, S., Getzenberg, R. H. & Partin, A. W. Biomarkers for prostate cancer. Annu. Rev. Med. 60, 139\u2013151 (2009).","journal-title":"Annu. Rev. Med."},{"key":"1406_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/gerona\/gly128","volume":"74","author":"J Huang","year":"2019","unstructured":"Huang, J. et al. Pre-diagnostic serum metabolomic profiling of prostate cancer survival. J. Gerontol. A Biol. Sci. Med Sci. 74, 853\u2013859 (2019).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cca.2019.10.046","volume":"501","author":"H Zheng","year":"2020","unstructured":"Zheng, H. et al. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer. Clin. Chim. Acta 501, 241\u2013251 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"1406_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03478-5","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Identification of characteristic metabolic panels for different stages of prostate cancer by (1)H NMR-based metabolomics analysis. J. Transl. Med. 20, 275 (2022).","journal-title":"J. Transl. Med."},{"key":"1406_CR19","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1021\/acs.jproteome.0c00282","volume":"19","author":"H Zheng","year":"2020","unstructured":"Zheng, H. et al. Distinct metabolic signatures of hormone-sensitive and castration-resistant prostate cancer revealed by a (1)H NMR-based metabolomics of biopsy tissue. J. Proteome Res. 19, 3741\u20133749 (2020).","journal-title":"J. Proteome Res."},{"key":"1406_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-23-1489","volume":"84","author":"RK Shrestha","year":"2024","unstructured":"Shrestha, R. K. et al. ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis. Cancer Res. 84, 2313\u20132332 (2024).","journal-title":"Cancer Res."},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2024.05.029","volume":"371","author":"MA Hamed","year":"2024","unstructured":"Hamed, M. A. et al. Prostate cancer-derived extracellular vesicles metabolic biomarkers: emerging roles for diagnosis and prognosis. J. Control Release 371, 126\u2013145 (2024).","journal-title":"J. Control Release"},{"key":"1406_CR22","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2018.05.015","volume":"173","author":"DM Camacho","year":"2018","unstructured":"Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C. & Collins, J. J. Next-generation machine learning for biological networks. Cell 173, 1581\u20131592 (2018).","journal-title":"Cell"},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1406_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03724-0","volume":"25","author":"J Dong","year":"2021","unstructured":"Dong, J. et al. Machine learning model for early prediction of acute kidney injury (AKI) in pediatric critical care. Crit. Care 25, 288 (2021).","journal-title":"Crit. Care"},{"key":"1406_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","volume":"601","author":"SJ Sammut","year":"2022","unstructured":"Sammut, S. J. et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature 601, 623\u2013629 (2022).","journal-title":"Nature"},{"key":"1406_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/JU.0000000000004421","volume":"213","author":"JJ Tosoian","year":"2025","unstructured":"Tosoian, J. J. et al. Clinical validation of MyProstateScore 2.0 testing using first-catch, non-digital rectal examination urine. J. Urol. 213, 581\u2013589 (2025).","journal-title":"J. Urol."},{"key":"1406_CR27","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3390\/cancers16091777","volume":"16","author":"J Chin","year":"2024","unstructured":"Chin, J. et al. Seeing is believing\u201d: additive utility of (68)ga-psma-11 pet\/ct in prostate cancer diagnosis. Cancers 16, 1777 (2024).","journal-title":"Cancers"},{"key":"1406_CR28","doi-asserted-by":"publisher","first-page":"107739","DOI":"10.1016\/j.biotechadv.2021.107739","volume":"49","author":"PS Reel","year":"2021","unstructured":"Reel, P. S., Reel, S., Pearson, E., Trucco, E. & Jefferson, E. Using machine learning approaches for multi-omics data analysis: A review. Biotechnol. Adv. 49, 107739 (2021).","journal-title":"Biotechnol. Adv."},{"key":"1406_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46043-y","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. Nat. Commun. 15, 1657 (2024).","journal-title":"Nat. Commun."},{"key":"1406_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","volume":"18","author":"A Joshi","year":"2021","unstructured":"Joshi, A., Rienks, M., Theofilatos, K. & Mayr, M. Systems biology in cardiovascular disease: a multiomics approach. Nat. Rev. Cardiol. 18, 313\u2013330 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1406_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48961-3","volume":"15","author":"J Hallqvist","year":"2024","unstructured":"Hallqvist, J. et al. Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset. Nat. Commun. 15, 4759 (2024).","journal-title":"Nat. Commun."},{"key":"1406_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-06016-w","volume":"25","author":"L Sun","year":"2024","unstructured":"Sun, L., Fan, X., Zhao, Y., Zhang, Q. & Jiang, M. Deep learning-based metabolomics data study of prostate cancer. BMC Bioinform. 25, 391 (2024).","journal-title":"BMC Bioinform."},{"key":"1406_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diagnostics9010021","volume":"9","author":"M Kdadra","year":"2019","unstructured":"Kdadra, M., Hockner, S., Leung, H., Kremer, W. & Schiffer, E. Metabolomics biomarkers of prostate cancer: a systematic review. Diagnostics 9, 21 (2019).","journal-title":"Diagnostics"},{"key":"1406_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102196","volume":"51","author":"Y Lopez-Hernandez","year":"2025","unstructured":"Lopez-Hernandez, Y. et al. Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: a systematic review. Transl. Oncol. 51, 102196 (2025).","journal-title":"Transl. Oncol."},{"key":"1406_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41585-024-00899-3","volume":"21","author":"L Galey","year":"2024","unstructured":"Galey, L. et al. Rediscovering citrate as a biomarker for prostate cancer. Nat. Rev. Urol. 21, 573\u2013575 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1406_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/bies.080137","volume":"31","author":"ME Mycielska","year":"2009","unstructured":"Mycielska, M. E. et al. Citrate transport and metabolism in mammalian cells: prostate epithelial cells and prostate cancer. Bioessays 31, 10\u201320 (2009).","journal-title":"Bioessays"},{"key":"1406_CR37","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/1878-0261.13441","volume":"17","author":"K Gonthier","year":"2023","unstructured":"Gonthier, K. et al. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer. Mol. Oncol. 17, 2109\u20132125 (2023).","journal-title":"Mol. Oncol."},{"key":"1406_CR38","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.7150\/thno.58655","volume":"11","author":"A Mukha","year":"2021","unstructured":"Mukha, A. et al. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy. Theranostics 11, 7844\u20137868 (2021).","journal-title":"Theranostics"},{"key":"1406_CR39","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104, 19345\u201319350 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1406_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu, J. & Thompson, C. B. Metabolic regulation of cell growth and proliferation. Nat. Rev. Mol. Cell Biol. 20, 436\u2013450 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1406_CR41","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1038\/s41388-021-02008-9","volume":"40","author":"E Labanca","year":"2021","unstructured":"Labanca, E. et al. Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. Oncogene 40, 6284\u20136298 (2021).","journal-title":"Oncogene"},{"key":"1406_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska, P. & Crawford, P. A. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 25, 262\u2013284 (2017).","journal-title":"Cell Metab."},{"key":"1406_CR43","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.4161\/cc.22137","volume":"11","author":"UE Martinez-Outschoorn","year":"2012","unstructured":"Martinez-Outschoorn, U. E. et al. Ketone body utilization drives tumor growth and metastasis. Cell Cycle 11, 3964\u20133971 (2012).","journal-title":"Cell Cycle"},{"key":"1406_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-017-1194-y","volume":"13","author":"C Perez-Rambla","year":"2017","unstructured":"Perez-Rambla, C. et al. Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia. Metabolomics 13, 52 (2017).","journal-title":"Metabolomics"},{"key":"1406_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21960-4","volume":"12","author":"S Coassolo","year":"2021","unstructured":"Coassolo, S. et al. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. Nat. Commun. 12, 1718 (2021).","journal-title":"Nat. Commun."},{"key":"1406_CR46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mrm.21694","volume":"60","author":"MB Tessem","year":"2008","unstructured":"Tessem, M. B. et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 60, 510\u2013516 (2008).","journal-title":"Magn. Reson. Med."},{"key":"1406_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601273","volume":"2","author":"J Meiser","year":"2016","unstructured":"Meiser, J. et al. Serine one-carbon catabolism with formate overflow. Sci. Adv. 2, e1601273 (2016).","journal-title":"Sci. Adv."},{"key":"1406_CR48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-024-00786-4","volume":"25","author":"P Altea-Manzano","year":"2025","unstructured":"Altea-Manzano, P., Decker-Farrell, A., Janowitz, T. & Erez, A. Metabolic interplays between the tumour and the host shape the tumour macroenvironment. Nat. Rev. Cancer 25, 274\u2013292 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"1406_CR49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/1541-7786.MCR-20-0548","volume":"19","author":"KL Penney","year":"2021","unstructured":"Penney, K. L. et al. Metabolomics of prostate cancer gleason score in tumor tissue and serum. Mol. Cancer Res. 19, 475\u2013484 (2021).","journal-title":"Mol. Cancer Res."},{"key":"1406_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.6004\/jnccn.2018.0036","volume":"16","author":"PH Carroll","year":"2018","unstructured":"Carroll, P. H. & Mohler, J. L. NCCN guidelines updates: prostate cancer and prostate cancer early detection. J. Natl. Compr. Cancer Netw. 16, 620\u2013623 (2018).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"1406_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.aca.2017.09.019","volume":"991","author":"H Zheng","year":"2017","unstructured":"Zheng, H. et al. Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment. Anal. Chim. Acta 991, 68\u201375 (2017).","journal-title":"Anal. Chim. Acta"},{"key":"1406_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jmr.2009.11.012","volume":"202","author":"F Savorani","year":"2010","unstructured":"Savorani, F., Tomasi, G. & Engelsen, S. B. icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. J. Magn. Reson. 202, 190\u2013202 (2010).","journal-title":"J. Magn. Reson."},{"key":"1406_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","volume":"1277","author":"AH Emwas","year":"2015","unstructured":"Emwas, A. H. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods Mol. Biol. 1277, 161\u2013193 (2015).","journal-title":"Methods Mol. Biol."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01406-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:02:54Z","timestamp":1780617774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01406-0","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}